This is not surprising as we have shown that ETV5 expression is modulated by MAPK/ERK signalling, which is a point of convergence of many signalling pathways altered in bladder cancer, such as PI3K, EGFR, and RAS. The gene discussed is EGFR; the disease is urinary bladder cancer.